Galvanize Therapeutics: Funding, Investors & Team (Sep 2026)
Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitis symptoms, cardiac arrhythmias, and solid tumors. It was formed by Apple Tree Partners in 2022.
Galvanize Therapeutics has raised $100M across 1 funding round on record, the most recent a Series B of $100M announced in Sep 2022.
That round is above the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Galvanize Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Galvanize Therapeutics Funding Rounds
Galvanize Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Galvanize Therapeutics Funding Compared to Other Health Care Startups
Galvanize Therapeutics' latest round of $100M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Galvanize Therapeutics in Health Care and San Carlos
Companies Similar to Galvanize Therapeutics
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Galvanize Therapeutics Funding FAQs
What does Galvanize Therapeutics do?
Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitis symptoms, cardiac arrhythmias, and solid tumors. It was formed by Apple Tree Partners in 2022.
How much funding has Galvanize Therapeutics raised?
Galvanize Therapeutics has raised $100M across 1 round on record. The most recent is a Series B of $100M announced in Sep 2022.
When did Galvanize Therapeutics last raise funding?
Galvanize Therapeutics' most recent funding round on record is a Series B of $100M, announced in Sep 2022.
Who is the CEO of Galvanize Therapeutics?
Jonathan Waldstreicher is listed as CEO at Galvanize Therapeutics.
Where is Galvanize Therapeutics headquartered?
Galvanize Therapeutics is based in San Carlos, California, United States.
How many employees does Galvanize Therapeutics have?
Galvanize Therapeutics is in the 51-100 employee band.
How does Galvanize Therapeutics' funding compare to other Health Care startups?
Galvanize Therapeutics' latest round of $100M is above the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Galvanize Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Galvanize Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.